Junyong Weng
Overview
Explore the profile of Junyong Weng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mei H, Luo Q, Weng J, Hao J, Cai J, Zhou R, et al.
Cell Mol Biol Lett
. 2025 Jan;
30(1):17.
PMID: 39891048
No abstract available.
2.
Zhang R, Chen F, Weng J, Ye Z, Li X
J Cancer Res Ther
. 2025 Jan;
20(7):2013-2020.
PMID: 39792411
Objective: Carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) serve as pivotal tumor markers in colorectal cancer (CRC). However, uncertainty persists regarding the prognostic significance of the two tumor markers...
3.
Mei H, Luo Q, Weng J, Hao J, Cai J, Zhou R, et al.
Cell Mol Biol Lett
. 2024 Nov;
29(1):144.
PMID: 39587482
Background: Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer-related death. This research focuses on investigating the impact and underlying molecular mechanisms...
4.
Li C, Weng J, Yang L, Gong H, Liu Z
Front Immunol
. 2024 May;
15:1378305.
PMID: 38779664
The effect of anoikis-related genes (ARGs) on clinicopathological characteristics and tumor microenvironment remains unclear. We comprehensively analyzed anoikis-associated gene signatures of 1057 colorectal cancer (CRC) samples based on 18 ARGs....
5.
Liu Q, Zhang Y, Li H, Gao H, Zhou Y, Luo D, et al.
Cell Commun Signal
. 2024 May;
22(1):278.
PMID: 38762737
Background: While de novo cholesterol biosynthesis plays a crucial role in chemotherapy resistance of colorectal cancer (CRC), the underlying molecular mechanism remains poorly understood. Methods: We conducted cell proliferation assays...
6.
Zhu Z, Li M, Weng J, Li S, Guo T, Guo Y, et al.
Cancer Lett
. 2024 Mar;
589:216828.
PMID: 38521199
5-Fluorouracil (5-FU) resistance has always been a formidable obstacle in the adjuvant treatment of advanced colorectal cancer (CRC). In recent years, long non-coding RNAs have emerged as key regulators in...
7.
Li S, Weng J, Xiao C, Lu J, Cao W, Song F, et al.
Cancer Rep (Hoboken)
. 2023 Oct;
6(12):e1904.
PMID: 37885090
Background: Cuproptosis has been studied in various aspects as a new form of cell death. Aims: We hope to explore the molecular patterns and genes related to cuproptosis in evaluating...
8.
Li S, Zhu Z, Lu J, Cao W, Song F, Xiao C, et al.
Front Oncol
. 2023 Sep;
13:1159126.
PMID: 37746284
Background: The correlations between cuproptosis and long noncoding RNAs (lncRNAs) with the tumor microenvironment (TME), immunotherapy, and some other characteristics of hepatocellular carcinoma (HCC) remain unclear. Methods: Sixteen cuproptosis regulators...
9.
Zhu Z, Guo T, Weng J, Li S, Zhu C, Zhao Q, et al.
Cancer Med
. 2023 Jun;
12(15):16661-16678.
PMID: 37334893
Background: A novel form of cell death termed cuproptosis was proposed recently. miRNAs play important roles in colorectal cancer (CRC). However, their relationships have not been reported. Methods: miRNAs that...
10.
Zhu Z, Zhao Q, Li S, Weng J, Guo T, Zhu C, et al.
Front Genet
. 2022 Dec;
13:984743.
PMID: 36467996
Cuproptosis is a novel form of cell death discovered in recent. A great quantity of researches has confirmed the close relationships and crucial roles between long non-coding RNAs (lncRNAs) with...